Commonwealth legislation

Therapeutic Goods (Listing) Notice 2012 (No. 2)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

2/10 complexity

This notice allows a specific type of magnesium supplement—magnesium citrate - dibasic tetrahydrate—to be sold in Australia as a "listed" medicine.

What this means:

Listed medicines are lower-risk therapeutic goods (like vitamins and mineral supplements) that can be sold over-the-counter without the extensive testing required for prescription drugs. They must be included in the Australian Register of Therapeutic Goods (ARTG).
The ingredient: This notice specifically permits products containing magnesium citrate - dibasic tetrahydrate as an active ingredient.
The restriction: These products must be for oral use only (tablets, capsules, or liquids you swallow—not injections, creams, or other forms).

Why this exists: This is a temporary approval. The notice acts as a placeholder until permanent regulations can be updated to formally include this ingredient in the official list of approved substances for listed medicines. Once those regulations change, this notice automatically expires.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Therapeutic Goods (Listing) Notice 2012 (No. 2).

Therapeutic Goods (Listing) Notice 2012 (No. 2)

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2012 (No. 2)

I, BRIAN RICHARDS, National Manager (Acting) of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:

preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘magnesium citrate - dibasic tetrahydrate’ as a therapeutically active ingredient, subject to the following condition:

o the preparations are for oral use only.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Pursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.

Dated this 1st day of May 2012

(signed by)

Brian Richards

Delegate of the Minister for Health

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 Therapeutic Goods (Listing) Notice 2012 (No. 2)

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2012 (No. 2)

preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘magnesium citrate - dibasic tetrahydrate’ as a therapeutically active ingredient, subject to the following condition:

o the preparations are for oral use only.

This Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.

Dated this 1st day of May 2012

(signed by)

Brian Richards

Delegate of the Minister for Health